Table 1 Baseline characteristics of the study group with IgAN
From: Vitamin D deficiency may predict a poorer outcome of IgA nephropathy
|  | Total (n = 105) |
|---|---|
Age (year) | 34.73 ± 12.19 |
Male (n/%) | 57(54.3Â %) |
Smoker (n/%) | 32(30.5Â %) |
Body mass index (kg/m2) | 23.2 ± 3.18 |
Systolic blood pressure (mmHg) | 131.21 ± 23.43 |
Diastolic blood pressure (mmHg) | 81.57 ± 16.84 |
Microscopic hematuria (n/%) | 67 (63.8Â %) |
Proteinuria(g/24 h) | 2.04 ± 1.09 |
eGFR (mL/min/1.73 m2) | 75.45 ± 39.18 |
Serum albumin (mg/dL) | 33.88 ± 7.91 |
Serum total cholesterol (mg/dL) | 5.76 ± 2.09 |
Serum IgA (mg/dL) | 2.97 ± 1.92 |
Uric acid (mg/dL) | 404.81 ± 123.59 |
Medical treatment (n/%) | |
 RAS blockers | 83 (79 %) |
 Immunosuppressant | 38 (36.2 %) |